Explore more publications!
Everything Worth Reading
Submit Press Release

Everything Worth Reading Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation
October 28, 2025

Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation

Neutral EIN Presswire
Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation
October 28, 2025

Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation

Neutral EIN Presswire
Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation
October 28, 2025

Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation

Neutral EIN Presswire
Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation
October 28, 2025

Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation

Neutral EIN Presswire
Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation
October 28, 2025

Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation

Neutral EIN Presswire
Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation
October 28, 2025

Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation

Neutral EIN Presswire
Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation
October 28, 2025

Norgen Biotek Launches Another Novel First-of-Its-Kind Kit for Bacterial Extracellular Vesicles Isolation

Neutral EIN Presswire
Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via a novel mechanism with DCAF16 E3 ligase published in Nature Communications
October 27, 2025

Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via a novel mechanism with DCAF16 E3 ligase published in Nature Communications

Indeterminate GlobeNewswire, Inc.
R.J. Halbert's Caretaker Awarded the 2025 Silver Bill Fisher Award and Gold American Legacy Book Awards
October 26, 2025

R.J. Halbert's Caretaker Awarded the 2025 Silver Bill Fisher Award and Gold American Legacy Book Awards

Neutral EIN Presswire
ARANTZA GARCIA FROM SOUTH AUSTRALIA CROWNED 2025 AUSTRALIAN POETRY SLAM CHAMPION
October 27, 2025

ARANTZA GARCIA FROM SOUTH AUSTRALIA CROWNED 2025 AUSTRALIAN POETRY SLAM CHAMPION

Neutral EIN Presswire
Levicept Presents New Data Suggesting a Novel Neurotrophin-3 Inhibitor, LEVI-04, May Modify Disease and Improve Symptoms in Osteoarthritis
October 27, 2025

Levicept Presents New Data Suggesting a Novel Neurotrophin-3 Inhibitor, LEVI-04, May Modify Disease and Improve Symptoms in Osteoarthritis

Indeterminate GlobeNewswire, Inc.
White Paper Published on HER2-Low Breast Cancer: the Case for Molecular Diagnostics
October 27, 2025

White Paper Published on HER2-Low Breast Cancer: the Case for Molecular Diagnostics

Neutral EIN Presswire
Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease
October 26, 2025

Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease

Indeterminate GlobeNewswire, Inc.
NEW VERSION OF NIEMOPEN REVEALED
November 17, 2025

NEW VERSION OF NIEMOPEN REVEALED

Neutral EIN Presswire
Suspenseful New Novel 'Flight Path' Explores Self-Discovery Amid Lies and Loss
October 24, 2025

Suspenseful New Novel 'Flight Path' Explores Self-Discovery Amid Lies and Loss

Neutral EIN Presswire
Coffeetown Releases Leta Serafim’s Latest Mystery Novel THE NAMELESS DEAD
October 24, 2025

Coffeetown Releases Leta Serafim’s Latest Mystery Novel THE NAMELESS DEAD

Neutral EIN Presswire
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
November 17, 2025

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

Indeterminate GlobeNewswire, Inc.
Kinetic Digital Publishers Brings All-In-One Solutions for Publishing and Marketing Services to Authors
October 22, 2025

Kinetic Digital Publishers Brings All-In-One Solutions for Publishing and Marketing Services to Authors

Neutral EIN Presswire
Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101
November 17, 2025

Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101

Indeterminate GlobeNewswire, Inc.
Seth Leitman Launches 'The Green Living Guy' Graphic Novel to Inspire Sustainable Living
October 24, 2025

Seth Leitman Launches 'The Green Living Guy' Graphic Novel to Inspire Sustainable Living

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions